🇺🇸 Inhaled Corticosteroids (ICs) in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Chronic Obstructive Pulmonary Disease — 1 report (100%)
Other Respiratory/Pulmonology approved in United States
Frequently asked questions
Is Inhaled Corticosteroids (ICs) approved in United States?
Inhaled Corticosteroids (ICs) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Inhaled Corticosteroids (ICs) in United States?
Parc de Salut Mar is the originator. The local marketing authorisation holder may differ — check the official source linked above.